The future is now: The role of precision medicine in advanced prostate cancer and bladder cancer

Learning objective:         

After participating in this symposium, attendees should be able to:

• Describe the potential benefits of precision medicine, considering the complexity and diversity in disease states of patients with advanced prostate cancer and bladder cancer
• Discuss the current state of precision medicine and the treatment modalities available for patients with advanced prostate cancer and bladder cancer
• Understand the importance of molecular pathology in determining in the future the most appropriate treatment course for patients

Scientific Committee:

• Noel Clarke (UK)
• Ignacio Durán (Spain)
• Antonio Lopez-Beltran (Portugal)